{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T17:05:09Z","timestamp":1754154309924,"version":"3.41.2"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,23]]},"DOI":"10.7759\/cureus.88634","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T04:37:06Z","timestamp":1753331826000},"source":"Crossref","is-referenced-by-count":0,"title":["Pericardial Calcification Following Acute Myopericarditis After Initial CHOP Treatment for Mantle Cell Lymphoma: A Case Report"],"prefix":"10.7759","author":[{"given":"Keishi","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Shirasugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eriya","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Narukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yurika","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02705-8","article-title":"B-cell non-Hodgkin lymphomas","volume":"403","author":"Silkenstedt E","year":"2024","unstructured":"Silkenstedt E, Salles G, Campo E, Dreyling M. B-cell non-Hodgkin lymphomas. Lancet. 2024, 403:1791-807. 10.1016\/S0140-6736(23)02705-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30031-4","article-title":"Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis","volume":"7","author":"Linschoten M","year":"2020","unstructured":"Linschoten M, Kamphuis JAM, van Rhenen A, et al.. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis. Lancet Haematol. 2020, 7:295-308. 10.1016\/S2352-3026(20)30031-4","journal-title":"Lancet Haematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.029574","article-title":"Circulating cardiovascular biomarkers in cancer therapeutics-related cardiotoxicity: review of critical challenges, solutions, and future directions","volume":"12","author":"Murtagh G","year":"2023","unstructured":"Murtagh G, Januzzi JL, Scherrer-Crosbie M, et al.. Circulating cardiovascular biomarkers in cancer therapeutics-related cardiotoxicity: review of critical challenges, solutions, and future directions. J Am Heart Assoc. 2023, 12:e029574. 10.1161\/JAHA.123.029574","journal-title":"J Am Heart Assoc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.303633","article-title":"Cardio-oncology: an update on cardiotoxicity of cancer-related treatment","volume":"118","author":"Lenneman CG","year":"2016","unstructured":"Lenneman CG, Sawyer DB. Cardio-oncology: an update on cardiotoxicity of cancer-related treatment. Circ Res. 2016, 118:1008-20. 10.1161\/CIRCRESAHA.115.303633","journal-title":"Circ Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann J","year":"2022","unstructured":"Herrmann J, Lenihan D, Armenian S, et al.. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2022, 43:280-99. 10.1093\/eurheartj\/ehab674","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121059","article-title":"Pericardial disease: value of CT and MR imaging","volume":"267","author":"Bogaert J","year":"2013","unstructured":"Bogaert J, Francone M. Pericardial disease: value of CT and MR imaging. Radiology. 2013, 267:340-56. 10.1148\/radiol.13121059","journal-title":"Radiology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler Y","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al.. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015, 36:2921-64. 10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-018-0654-7","article-title":"Pericardial disease in cancer patients","volume":"20","author":"Ghosh AK","year":"2018","unstructured":"Ghosh AK, Crake T, Manisty C, Westwood M. Pericardial disease in cancer patients. Curr Treat Options Cardiovasc Med. 2018, 20:60. 10.1007\/s11936-018-0654-7","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702592","article-title":"Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure","volume":"26","author":"Yamamoto R","year":"2000","unstructured":"Yamamoto R, Kanda Y, Matsuyama T, et al.. Myopericarditis caused by cyclophosphamide used to mobilize peripheral blood stem cells in a myeloma patient with renal failure. Bone Marrow Transplant. 2000, 26:685-8. 10.1038\/sj.bmt.1702592","journal-title":"Bone Marrow Transplant"},{"key":"ref10","article-title":"Pericardial calcification","author":"Khalid N","year":"2023","unstructured":"Khalid N, Hussain K, Shlofmitz E. Pericardial calcification. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-017-0590-y","article-title":"Multimodality imaging of pericardial diseases","volume":"19","author":"Al-Mallah MH","year":"2017","unstructured":"Al-Mallah MH, Almasoudi F, Ebid M, Ahmed AM, Jamiel A. Multimodality imaging of pericardial diseases. Curr Treat Options Cardiovasc Med. 2017, 19:89. 10.1007\/s11936-017-0590-y","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1367467","article-title":"Extensive myocardial calcifications: a systematic literature review of a rare pathological phenomenon","volume":"11","author":"Sozzi FB","year":"2024","unstructured":"Sozzi FB, Gnan E, Faggiano A, et al.. Extensive myocardial calcifications: a systematic literature review of a rare pathological phenomenon. Front Cardiovasc Med. 2024, 11:1367467. 10.3389\/fcvm.2024.1367467","journal-title":"Front Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0728-4","article-title":"The imaging appearances of various pericardial disorders","volume":"10","author":"\u00dcnal E","year":"2019","unstructured":"\u00dcnal E, Karcaaltincaba M, Akpinar E, Ariyurek OM. The imaging appearances of various pericardial disorders. Insights Imaging. 2019, 10:42. 10.1186\/s13244-019-0728-4","journal-title":"Insights Imaging"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2019.07.005","article-title":"Myocardial calcification in a patient with B-lymphoblastic leukemia accompanied by tumor lysis syndrome","volume":"43","author":"Usui G","year":"2019","unstructured":"Usui G, Hashimoto H, Uchibori Y, Usuki K, Horiuchi H, Morikawa T. Myocardial calcification in a patient with B-lymphoblastic leukemia accompanied by tumor lysis syndrome. Cardiovasc Pathol. 2019, 43:107146. 10.1016\/j.carpath.2019.07.005","journal-title":"Cardiovasc Pathol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960130410","article-title":"Calcific deposits in the heart","volume":"13","author":"Catellier MJ","year":"1990","unstructured":"Catellier MJ, Chua GT, Youmans G, Waller BF. Calcific deposits in the heart. Clin Cardiol. 1990, 13:287-94. 10.1002\/clc.4960130410","journal-title":"Clin Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376838-pericardial-calcification-following-acute-myopericarditis-after-initial-chop-treatment-for-mantle-cell-lymphoma-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T04:37:08Z","timestamp":1753331828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376838-pericardial-calcification-following-acute-myopericarditis-after-initial-chop-treatment-for-mantle-cell-lymphoma-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.88634","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}